Literature DB >> 25471309

Transcription: Super-enhanced.

Sarah Seton-Rogers.   

Abstract

Year:  2014        PMID: 25471309     DOI: 10.1038/nrc3879

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  3 in total

1.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

2.  CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.

Authors:  Edmond Chipumuro; Eugenio Marco; Camilla L Christensen; Nicholas Kwiatkowski; Tinghu Zhang; Clark M Hatheway; Brian J Abraham; Bandana Sharma; Caleb Yeung; Abigail Altabef; Antonio Perez-Atayde; Kwok-Kin Wong; Guo-Cheng Yuan; Nathanael S Gray; Richard A Young; Rani E George
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

3.  Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.

Authors:  Yumi Yashiro-Ohtani; Hongfang Wang; Chongzhi Zang; Kelly L Arnett; Will Bailis; Yugong Ho; Birgit Knoechel; Claudia Lanauze; Lumena Louis; Katherine S Forsyth; Sujun Chen; Yoonjie Chung; Jonathan Schug; Gerd A Blobel; Stephen A Liebhaber; Bradley E Bernstein; Stephen C Blacklow; Xiaole Shirley Liu; Jon C Aster; Warren S Pear
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

  3 in total
  1 in total

1.  Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domains.

Authors:  Carlo Zanon; Gian Paolo Tonini
Journal:  Mol Oncol       Date:  2017-10-10       Impact factor: 6.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.